Enanta Pharmaceuticals
ENTA
$12.74
Share price
3.03%
Change (1 day)
-64.15%
Change (1 year)
Categories
Enanta Pharmaceuticals (ENTA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.23 B
According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are $0.23 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-09-30 | $0.24 B | 354.06% |
| 2022-09-30 | $54.07 M | 37.38% |
| 2021-09-30 | $39.36 M | 28.84% |
| 2020-09-30 | $30.55 M | 11.76% |
| 2019-09-30 | $27.33 M | 33.04% |
| 2018-09-30 | $20.54 M | -17.68% |
| 2017-09-30 | $24.96 M | 120.1% |
| 2016-09-30 | $11.34 M | 15.07% |
| 2015-09-30 | $9.85 M | 45.78% |
| 2014-09-30 | $6.76 M | 3.94% |
| 2013-09-30 | $6.5 M | -20.99% |
| 2012-09-30 | $8.23 M | 98.77% |
| 2011-09-30 | $4.14 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 41,648.83% | 🇺🇸 USA |
 Novartis NVS | $54.57 B | 22,966.16% | 🇨🇭 Switzerland |
 AbbVie ABBV | $124.31 B | 52,438.51% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $5.14 B | 2,076.45% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 29,078.20% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $82.48 B | 34,759.58% | 🇺🇸 USA |